Vimarsana
Biggest News Aggregation in the World

Jan De Witte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jan De Witte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jan De Witte Today - Breaking & Trending Today

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript - Vimarsana News

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript

Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.

Integra Lifesciences Reports Subdued Earnings Amidst Market Stability and Product Resilience - Vimarsana News

Integra Lifesciences Reports Subdued Earnings Amidst Market Stability and Product Resilience

Full-Year Revenue Sees Slight Decline as Company Prepares for 2024 with Strategic Acquisitions and Product Relaunches

Source: yahoo.com
Integra LifeSciences Q4 Adj. Profit Declines, Organic Revenues Down 1.2%; Jan De Witte To Retire - Vimarsana News

Integra LifeSciences Q4 Adj. Profit Declines, Organic Revenues Down 1.2%; Jan De Witte To Retire

Integra LifeSciences Holdings Corporation (IART) reported fourth quarter GAAP net income of $19.8 million, or $0.25 per share, compared to $52.9 million, or $0.63 per share, in the prior year.

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

05.01.2024 - PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the ...

Integra LifeSciences to buy Johnson & Johnson's Acclarent - Vimarsana News

Integra LifeSciences to buy Johnson & Johnson's Acclarent

Integra LifeSciences announced that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech.